Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
Kahkoska AR, Abrahamsen TJ, Alexander GC, Bennett TD, Chute CG, Haendel MA, Klein KR, Mehta H, Miller JD, Moffitt RA, Stürmer T, Kvist K, Buse JB; N3C Consortium.
Kahkoska AR, et al. Among authors: klein kr.
Diabetes Care. 2021 Jul;44(7):1564-1572. doi: 10.2337/dc21-0065. Epub 2021 Jun 16.
Diabetes Care. 2021.
PMID: 34135013
Free PMC article.